(Q37412304)

English

Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors

scientific article published on 14 September 2009

Statements

Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors (English)
Pravin T P Kaumaya
Kevin Chu Foy
Joan Garrett
Sharad V Rawale
Daniele Vicari
Jennifer M Thurmond
Tammy Lamb
Aruna Mani
Yahaira Kane
Catherine R Balint
Donald Chalupa
Gregory A Otterson
Charles L Shapiro
Jeffrey M Fowler
Michael R Grever
Tanios S Bekaii-Saab
William E Carson
14 September 2009
5270-5277

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit